{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:42:54Z","timestamp":1778272974218,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2024.1371468","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:04:43Z","timestamp":1709701483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Lukas","family":"Andereggen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Christ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1285477","article-title":"Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11102-008-0097-3","article-title":"The effects of hyperprolactinemia on bone and fat","volume":"12","author":"Shibli-Rahhal","year":"2009","journal-title":"Pituitary"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"dos Santos Silva","year":"2011","journal-title":"Obes (Silver Spring)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9882-2","article-title":"Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas","volume":"32","author":"Schwetz","year":"2017","journal-title":"Metab Brain Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0286","article-title":"Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis","volume":"8","author":"Byberg","year":"2019","journal-title":"Endocr Connect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2020.09.001","article-title":"Association between prolactinoma and body mass index","volume":"27","author":"Al Sabie","year":"2020","journal-title":"Endocr Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2006.10955","article-title":"Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma","volume":"136","author":"Schmid","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/s41598-021-84606-x","article-title":"Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas","volume":"11","author":"Andereggen","year":"2021","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1250392","article-title":"Prolactinoma and body weight: a retrospective study","volume":"125","author":"Creemers","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2006.12.001","article-title":"Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI","volume":"62","author":"Choi","year":"2007","journal-title":"Clin Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"w14521","DOI":"10.4414\/smw.2018.14521","article-title":"A ten-year follow-up study of treatment outcome of craniopharyngiomas","author":"Andereggen","year":"2018","journal-title":"Swiss Med Wkly 148"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0473","article-title":"Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis","volume":"186","author":"Mangolim","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100258","DOI":"10.1016\/j.jcte.2021.100258","article-title":"Impact of primary medical or surgical therapy on prolactinoma patients\u2019 BMI and metabolic profile over the long-term","volume":"24","author":"Andereggen","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.695498","article-title":"Commentary: \u201cProlactinomas: prognostic factors of early remission after transsphenoidal surgery\u201d","volume":"12","author":"Andereggen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.wneu.2016.10.059","article-title":"Long-term follow-up of primary medical versus surgical treatment of prolactinomas in men: effects on hyperprolactinemia, hypogonadism, and bone health","volume":"97","author":"Andereggen","year":"2017","journal-title":"World Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1115-2","article-title":"10-year follow-up study comparing primary medical vs","volume":"55","author":"Andereggen","year":"2017","journal-title":"Surg Ther Women prolactinomas. Endocrine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01569-6","article-title":"First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center","volume":"44","author":"Andereggen","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.967407","article-title":"Prolactinomas in adolescent and elderly patients-A comparative long-term analysis","volume":"10","author":"Andereggen","year":"2023","journal-title":"Front Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6823-10-10","article-title":"Prolactinomas, Cushing\u2019s disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas","volume":"10","author":"Biller","year":"2010","journal-title":"BMC Endocr Disord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/dom.14183","article-title":"The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials","volume":"23","author":"Andersen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1174119","article-title":"Medical treatment of Cushing\u2019s disease with concurrent diabetes mellitus","volume":"14","author":"Mehlich","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000377704","article-title":"Medical treatment of acromegaly with dopamine agonists or somatostatin analogs","volume":"103","author":"Chanson","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02557-1","article-title":"Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated","volume":"72","author":"Andereggen","year":"2021","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-023-01230-4","article-title":"Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis","volume":"22","author":"Dereje","year":"2023","journal-title":"J Diabetes Metab Disord"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000987","article-title":"Dopamine: a role in the pathogenesis and treatment of hypertension","author":"Murphy","year":"2000","journal-title":"J Hum Hypertens"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00327","article-title":"Glucose abnormalities associated to prolactin secreting pituitary adenomas","volume":"10","author":"Auriemma","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03525-1","article-title":"Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D","volume":"83","author":"Vranic","year":"2024","journal-title":"Endocrine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1371468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:04:45Z","timestamp":1709701485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1371468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":28,"alternative-id":["10.3389\/fendo.2024.1371468"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1371468","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"article-number":"1371468"}}